XENCO LABORATORIES
Xenco Laboratories is an environmental services company specializing in quality analytical testing services.
XENCO LABORATORIES
Industry:
Consulting Health Care Information Technology
Founded:
1990-01-01
Address:
Stafford, Texas, United States
Country:
United States
Website Url:
http://www.xenco.com
Total Employee:
101+
Status:
Active
Contact:
(210) 509-3334
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS Google Maps API Google Maps For Work Cisco Ironport Cloud Equinix Nameshield
Similar Organizations
Advanced Environmental Laboratories, Inc.
Advanced Environmental Laboratories is an environmental services company providing soil, sediment, and chemicals testing services.
Fairfax Radiological Consultants, PC
Fairfax Radiological Consultants is a medical practice company specializing in screening and diagnostic test services.
Heritage Interactive Services
Heritage Interactive Services is an environmental services company specializing in waste management services.
Rineco
Rineco is an environmental services company specializing in waste management services.
Stillwater Sciences
Stillwater Sciences is an environmental services company specializing in watershed analysis and restoration services.
Summit Environmental Technologies, Inc.
Summit Environmental Technologies, Inc is an Environmental Consultant and an analytical laboratory testing services provider in Ohio.
Official Site Inspections
http://www.xenco.com
- Host name: saspresence.perf1.com
- IP address: 81.92.80.55
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Xenco Laboratories"
Xencor | Proteins By Design®
Xencor is expanding the therapeutic boundaries of antibody drugs. Powered by its XmAb ® โฆSee details»
Xencor - Crunchbase Company Profile & Funding
Xencor provides protein engineering technology platforms in the biotechnology industry. Its products include antibody therapeutics, such as XmAb2513 for โฆSee details»
Xencor, Inc. Company Profile | Pasadena, CA - Dun & Bradstreet
Company Description: Xencor is a clinical-stage biopharmaceutical company focused on โฆSee details»
Investors | Xencor, Inc.
Oct 10, 2024 Since Xencorโs founding in 1997, investors have been drawn to our remarkable โฆSee details»
Home - Xenco Services
Understanding needs and challenges. Our approach is holistic, covering the full lifecycle of operations from inception to closure. We delve deep into understanding our clientsโ specific needs and challenges, crafting tailored โฆSee details»
Critical Insights From Xencor Analyst Ratings: What You Need
12 hours ago Revenue Growth: Xencor's revenue growth over a period of 3 months has faced โฆSee details»
Xencor, Inc. (XNCR) Company Profile & Overview - Stock Analysis
Dec 3, 2013 Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the โฆSee details»
Xencor Company Profile - Office Locations, Competitors, Revenue โฆ
Oct 2, 2024 Xencor has 5 employees across 2 locations and $168.34 m in annual revenue in โฆSee details»
Corporate Responsibility Statement - Xencor, Inc.
Participation across our organization, and our employees raised over $149,000. Team Xencor โฆSee details»
Xencor Highlights 2022 Corporate Priorities and Portfolio Milestones
Jan 11, 2022 Xencor is a clinical-stage biopharmaceutical company developing engineered โฆSee details»
Careers - Xencor
Or mail to Xencor: 111 W. Lemon Ave., Monrovia CA 91016. CONTACT US. [email protected] โฆSee details»
Xencor Enters Global Collaboration and License ... - Business Wire
Oct 4, 2021 Xencor is a clinical-stage biopharmaceutical company developing engineered โฆSee details»
Xencor | Pipeline
Xencor Headquarters 465 North Halstead Street, Suite 200 Pasadena, CA 91107 (626) 305-5900See details»
Caris and Xencor Enter Target Discovery Collaboration - Caris Life โฆ
Aug 2, 2022 IRVING, Texas and MONROVIA, California, August 2, 2022 โ Caris Life โฆSee details»
Press Release - Zenas BioPharma
Nov 21, 2021 Xencor receives rights to additional equity in Zenas as upfront payment and is โฆSee details»
Bart Cornelissen - Xencor
Apr 9, 2024 Before Xencor, Mr. Cornelissen was vice president, corporate finance at Seagen โฆSee details»
Zenas BioPharma Acquires Exclusive Worldwide Rights to โฆ
Nov 21, 2021 Xencor Investor Contact: Charles Liles [email protected] Xencor Media โฆSee details»
Xencor Announces XmAb Drug Candidates in Autoimmune โฆ
Sep 9, 2024 Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near โฆSee details»
Xencor | Technology
Xencor has built a world-leading intellectual property position around the Fc domain, which โฆSee details»